Cardiotropic action of combined use of celecoxib and amlodipine in rats sicked on adjuvant arthritis coupled with arterial hypertension

  • N. N. Seredinskaya State Institution «Institute of Pharmacology and Toxicology of the National Academy of Medical Sciences of Ukraine», Kyiv
  • A. A. Sushinskaya State Institution «Institute of Pharmacology and Toxicology of the National Academy of Medical Sciences of Ukraine», Kyiv
  • V. S. Chomenko State Institution «Institute of Pharmacology and Toxicology of the National Academy of Medical Sciences of Ukraine», Kyiv
  • Z. P. Omelyanenko State Institution «Institute of Pharmacology and Toxicology of the National Academy of Medical Sciences of Ukraine», Kyiv
  • T. A. Bershova State Institution «Institute of Pharmacology and Toxicology of the National Academy of Medical Sciences of Ukraine», Kyiv
Keywords: celecoxib, amlodipine, combined use, rheumatoid arthritis, arterial hypertension

Abstract

Drug therapy of rheumatoid arthritis combined with arterial hypertension is among actual medical objectives. The complexity of pharmacological treatment of comorbid state is due to not only pathological process severity, insufficient efficacy and side effects of disease modifying and symptomatic drugs but also property of nonsteroidal anti-inflammatory drugs (NSAIDs) to aggravate already existed arterial hypertension in patients with rheumatoid arthritis or to increase pressure. Many hypotensive drugs loose or don’t manifest their activity when used in combination with NSAIDs. High risk of cardio toxicity is registered for one of NSAIDs group – coxibs. The cardio safety of combined use of coxibs and hypotensive drugs on the ground of comorbid pathology is studied not enough.

These aspects had predefined the aim of this study – to investigate cardiotropic effects of celecoxib when administered in combinations with amlodipine on the ground of experimental rheumatoid arthritis coupled with arterial hypertension.

Arterial hypertension was modeled in rats by method of salt load. On the basis of arterial hypertension rheumatoid arthritis was caused by full Freund adjuvant injection. Arterial blood pressure and heart rate registered on sphygmomanometer.

It was found that comorbid state is followed by arterial hypertension and tachyarrhythmia. Celecoxib does not facilitate hypertension enhancing but leads to increasing heart rate. Amlodipine manifests specific pharmacological activity as hypotensive drug. The results obtained predefined opportunity of combined use of celecoxib with amlodipine on the ground of rheumatoid arthritis coupled with arterial hypertension.

References

1. Rheumatology: Klin. recommendations / ed. E. L. Nasonova. - M .: GEOTAR-MEDIA, 2010. - 752 p.
2. Karateev A.E. Application of nimesulida in rheumatology // Difficult patient. - 2010. - No. 6-7. - pp. 24-29.
3. Karateev A. E., Yakhno N. N., Lazebnik L. B., etc. The use of non-steroidal anti-inflammatory drugs: Klin. recommendations - Moscow: IMA-PRESS, 2009. - 167 p.
4. Fosbol E. L., Folke F., Jacobsen S. et al. Cause-specific cardiovascular risk associated with non-steroidal anti-inflammatory drugs among healthy individuals // Circ. Cardiovasc Qual Outcomes - 2010. - V. 3, N 4. - P. 395-405.
5. Bereznyakov, I.G., Korzh, IV. Osteoarthritis, arterial hypertension and obesity: the problem of comorbidity // International. honey. journ - 2012. - No. 4. - P. 78-81.
6. Nikitina N. M., Rebrov A. P. Cardiovascular risk in patients with rheumatoid arthritis // Ter. Arkh - 2009. - V. 81, N 6. - P. 29-34.
7. Wojciechowska M., Wątroba M., Ciużyńska G. et al. Ischaemic heart preconditioning in rats with adjuvant-induced arthritis // Cardiol. Pol - 2013. - V. 71, N 8. - P. 839-844.
8. Karateev AE. Celecoxib, etricoxib, meloxicam and nimesulide: advantages and disadvantages // EP. Rheumatology Traumatology Orthopedics - 2011. - No. 1. - P. 28-36.
9. Myasoedova S. E. Prevalence and risk factors of arterial hypertension in rheumatoid arthritis // Scientific-practical. rheumatol - 2012. - No. 2. - P. 31-34.
10. Gromova MA, Myasoedova S. E. Arterial hypertension, state of the cardiovascular system and the description of pain in patients with rheumatoid arthritis // Fund. researches. - 2014. - No. 10, Ch.4 - P. 651-653.
11. Atar D., Birkeland K.I., Uhlig T. "Treat to target": moving targets from hypertension, hyperlipidemia and diabetes to reimatoid arthritis // Ann. Rheum Dis - 2010. - N 69. - p. 629-630.
12. Antivalle M., Chevallard M., Battellino M. et al. Reduced response to biologic treatments in rheumatoid arthritis patients affected by arterial hypertension // Arthr. Rheum - 2013. - V. 65, N 10. - P. 462-465.
13. Trelle S., Reichenbach S., Wandel S. et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis // BMJ. - 2011. - P. 342: S7086.
14. Darren L. A., Ashley M. M., Iain B. Mc., Foo J. L., Animal models of rheumatoid arthritis // Eur. J. Immunol. - 2013. - V. 39, N 8. - P. 2040-2044.
15. Dornas W. C., Silva M. E. Animal models for studying arterial hypertension // J. Biosci. - 2011. - V. 36, N 4. - P. 731-737.
Published
2018-09-04
How to Cite
Seredinskaya, N. N., Sushinskaya, A. A., Chomenko, V. S., Omelyanenko, Z. P., & Bershova, T. A. (2018). Cardiotropic action of combined use of celecoxib and amlodipine in rats sicked on adjuvant arthritis coupled with arterial hypertension. Farmatsevtychnyi Zhurnal, (1), 91-97. https://doi.org/10.32352/0367-3057.1.16.04
Section
General and Clinical Pharmacology